Re:CD19-/CD10+/HLA-DR+ cells: results and thanks

From: Szeberenyi Julia (szebjul@net.sote.hu)
Date: Tue Jan 25 2000 - 12:43:02 EST


Dear Flow-ers,
I would like to thank everybody who helped in this case.
As to our possibilities, we performed these stainings:
surface CD21 (0%)
surface  CD22 (84%)
surface  kappa-chain (1.2%)
surface  lambda-chain (2.3%)
surface CD30 (0%)
surface CD38 (87%)
intracellular CD22 (75%)
intracellular kappa-chain (0.6%)
intracellular lambda-chain (97%)
intracellular CD3 (6.7%)
Based on these findings, we suppose that this is an immature B-cell 
leukaemia.

Thank you again for the quick responses,
Best regards, Julia
 

------- Forwarded Message Follows -------
From:          Self <SOTE-NET/SZEBJUL>
To: cyto-inbox
Subject:       CD19-/CD10+/HLA-DR+ cells?
Date:          Mon, 24 Jan 2000 16:06:53 GMT+100

Dear Flow-ers,
We got a bone marrow sample from a 5-year-old boy who has anaemia, 
thrombopenia and leukopenia, returning febrile status, leg pain.
We found that only 10% of bone marrow cells expressed CD45. 90% of 
the  blast-like cells were HLA-DR+ and CD10+, but they do not express 
CD19. The percentage of CD34+ cells are also very low (0.1%). We 
could not detect neither CD33 or CD13. 5% of the cells were positive 
for CD3, CD5 or C7. 
What kind of malignancy can this be?
I would appreciate any comments.
Julia

Julia B. Szeberenyi M.D
Dept. of Genetics, Cell-and Immunobiology
Laboratory of Flow Cytometry
Semmelweis University of Medicine
H-1089 Budapest, Nagyvarad ter 4
Hungary
email: szebjul@net.sote.hu
fax:+36-1-303-69-68



This archive was generated by hypermail 2b29 : Sat Mar 10 2001 - 19:31:04 EST